From Editing Genes to Orchestrating Networks: CRISPR and the Future of Precision Oncology

Abstract excerpt

The advent of CRISPR-based genome editing has transformed the conceptual framework of oncology—from descriptive molecular profiling to functional genome engineering. By enabling precise, programmable, and multiplex control of cancer-associated genes, CRISPR/Cas systems are reshaping how we model tumorigenesis, predict drug response, and design patient-tailored interventions. This Perspective discusses how CRISPR t...

Topics

Open a Topic to create a Post that cites this publication.

• CAR-T cell therapy research
• CRISPR and Genetic Engineering
• CRISPR-Cas Systems
• Gene Editing
• Genetic Therapy
• Genome, Human
• Mutation
• Protein Degradation and Inhibitors

Identifiers and source

Literature Corpus work

c0daaa0c-b2ff-5f41-b7fd-62cf571600e3

DOI

10.20944/preprints202511.1184.v1